scholarly journals Cognitive impairment in hypertensive patients: methods for the diagnosis and prevention

2021 ◽  
pp. 16-20
Author(s):  
V. А. Skybchyk ◽  
О. S. Pylypiv
Keyword(s):  
Cognitive Impairment ◽  
Early Detection ◽  
Cognitive Disorders ◽  
Primary Diagnosis ◽  
Hypertensive Patients ◽  
Cognitive Disorders And Dementia ◽  
Early Detection And Prevention

The review presents modern views on the problem of cognitive inpairment in hypertensive patients, provides examples of the most common screening scales for the primary diagnosis of cognitive disorders and dementia, and confirms the need for early detection and prevention of these disorders.

scholarly journals Awareness of Medical Workers with Early Diagnosis of Cognitive Disorders at the Primary Health Care Level in the Republic of Kazakhstan

2020 ◽  
Vol 8 (E) ◽  
pp. 595-600
Author(s):  
Assel Tukinova ◽  
Gulnar M. Shalgumbayeva ◽  
Zhanna A. Mussabekova ◽  
Roza A. Abzalova
Keyword(s):  
Cognitive Impairment ◽  
Early Detection ◽  
Early Diagnosis ◽  
Work Experience ◽  
Cognitive Disorders ◽  
The Elderly ◽  
Cross Sectional Study ◽  
Cross Sectional ◽  
Region Of Residence ◽  
The Republic

   BACKGROUND: Early detection of cognitive impairments (CIs) has been identified as one of the most important factors for the treatment of the disease. The World Alzheimer report 2011 states that the earlier a diagnosis is known, the better patients can be treated medically, patients and their family members can adapt to the development and learn to deal with the disease. Early diagnosis also leads to higher cost-effectivity, which will further improve, when treatments and social care interventions become more effective in future. It is the first-contact doctor who becomes the main figure in identifying the patient’s cognitive disorders. AIM: This study aimed to research the awareness of medical workers with early diagnosis of cognitive disorders at the PHC level in Kazakhstan. METHODS: It was a cross-sectional study. A survey of primary healthcare workers was conducted to study the early diagnosis of CI in the elderly in the period from December 2019 to March 2020. The questionnaire was developed independently according to international finding and experiences and passed the validation process. The questionnaire included questions such as age, gender, nationality, education, specialty, work experience, conduct early diagnosis of CI or not, what methods respondents know, time available for admission for early diagnosis, desire to learn early diagnosis methods, and the region of residence. RESULTS: The total number of respondents was 823. To the question, “Do you check older patients for early cognitive impairment?” 335 (40.7%) answered “no.” To the question “Do you have time to use methods for the early diagnosis of cognitive impairment in the elderly during admission?” “no” – 354 (43%). To the question “Would you like to learn methods for the early diagnosis of cognitive impairment in the elderly?” The answer was “yes” 759 (92.2%) of respondents. This study reveals that the presence of time during admission, the region of residence, and the desire to study affect whether elder people check for early CI or not, in turn, specialty, education, gender, nationality, age, and work experience do not affect. We have identified a relationship of age, region of residence with the availability of time during admission to use methods for early diagnosis of CI, while it was absent with work experience. The region of residence, the availability of time during admission, and education influenced the respondents’ desire to learn early diagnosis methods, while age and work experience did not. CONCLUSION: The problem of early diagnosis of CI in the elderly at the PHC level is relevant and not fully understood. Early detection of CI at the PHC level is a key element in the fight against such a serious condition as dementia.

scholarly journals Algorithm prediction of cognitive impairment

2015 ◽  
pp. 28-38
Author(s):  
N.K. Svyrydova ◽  
T.P. Parnikoza ◽  
G.M. Chupryna ◽  
R.V. Sulikom ◽  
G.S. Lubenets ◽  
...  
Keyword(s):  
Risk Factor ◽  
Cognitive Impairment ◽  
Independent Risk Factor ◽  
Neuropsychological Testing ◽  
Cerebral Arteries ◽  
Cognitive Disorders ◽  
Hypertensive Patients ◽  
Rate Of Progression ◽  
The Brain ◽  
Therapeutic Profile

The most strong and independent risk factor for cognitive disorders are age because the brain undergoes a series of regular changes that make it more vulnerable to various pathological effects. Diagnosis of cognitive impairment in patients with atherosclerosis of coronary and cerebral arteries in the early stages of development (for example, at the stage of mild cognitive disorders) hard due to ignorance of doctors therapeutic profile of peculiarities and rate of progression of cognitive impairment in hypertensive patients, especially their maintenance and necessary neuropsychological testing.

Modern prevention and active longevity programs on the basis of disruptive domestic technologies: positive experience and prospects for application

2020 ◽  
pp. 66-73
Author(s):  
A. Simonova ◽  
S. Chudakov ◽  
R. Gorenkov ◽  
V. Egorov ◽  
A. Gostry ◽  
...  
Keyword(s):  
Personalized Medicine ◽  
Early Detection ◽  
Laboratory Diagnostics ◽  
Positive Experience ◽  
Practical Application ◽  
Wide Range ◽  
Integrated Program ◽  
Long Term Experience ◽  
Early Detection And Prevention

The article summarizes the long-term experience of practical application of domestic breakthrough technologies of preventive personalized medicine for laboratory diagnostics of a wide range of socially significant non-infectious diseases. Conceptual approaches to the formation of an integrated program for early detection and prevention of civilization diseases based on these technologies are given. A vision of the prospects for the development of this area in domestic and foreign medicine has been formed.

The Oxford Handbook of Adult Cognitive Disorders

2019 ◽  
Keyword(s):  
Cognitive Impairment ◽  
Cognitive Function ◽  
Neurodevelopmental Disorders ◽  
Brain Aging ◽  
Cognitive Disorders ◽  
Diverse Range ◽  
Medical Specialties ◽  
Psychiatric Illnesses ◽  
Medical Disorders ◽  
The Impact

The prevalence of cognitive impairment caused by neurodegenerative diseases and other neurologic disorders associated with aging is expected to rise dramatically between now and year 2050, when the population of Americans aged 65 or older will nearly double. Cognitive impairment also commonly occurs in other neurologic conditions, as well as in non-neurologic medical disorders (and their treatments), idiopathic psychiatric illnesses, and adult neurodevelopmental disorders. Cognitive impairment can thus infiltrate all aspects of healthcare, making it necessary for clinicians and clinical researchers to have an integrated knowledge of the spectrum of adult cognitive disorders. The Oxford Handbook of Adult Cognitive Disorders is meant to serve as an up-to-date, scholarly, and comprehensive volume covering most diseases, conditions, and injuries resulting in impairments in cognitive function in adults. Topics covered include normal cognitive and brain aging, the impact of medical disorders (e.g., cardiovascular, liver, pulmonary) and psychiatric illnesses (e.g., depression and bipolar disorder) on cognitive function, adult neurodevelopmental disorders (e.g., Down Syndrome, Attention Deficit/Hyperactivity Disorder), as well as the various neurological conditions (e.g., Alzheimer’s disease, chronic traumatic encephalopathy, concussion). A section of the Handbook is also dedicated to unique perspectives and special considerations for the clinicians and clinical researchers, covering topics such as cognitive reserve, genetics, diversity, and neuroethics. The target audience of this Handbook includes: (1) clinicians, particularly psychologists, neuropsychologists, neurologists (including behavioral and cognitive neurologists), geriatricians, and psychiatrists (including neuropsychiatrists), who provide clinical care and management for adults with a diverse range of cognitive disorders; (2) clinical researchers who investigate cognitive outcomes and functioning in adult populations; and (3) graduate level students and post-doctoral trainees studying psychology, clinical neuroscience, and various medical specialties.

Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI)

2021 ◽  
Vol 2021 (7) ◽  
Author(s):  
Ingrid Arevalo-Rodriguez ◽  
Nadja Smailagic ◽  
Marta Roqué-Figuls ◽  
Agustín Ciapponi ◽  
Erick Sanchez-Perez ◽  
...  
Keyword(s):  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Early Detection ◽  
Mental State ◽  
Mini Mental State Examination ◽  
State Examination

scholarly journals The Role of High Triglycerides Level in Predicting Cognitive Impairment: A Review of Current Evidence

Nutrients ◽  
2021 ◽  
Vol 13 (6) ◽  
pp. 2118
Author(s):  
Alina Mihaela Dimache ◽  
Delia Lidia Șalaru ◽  
Radu Sascău ◽  
Cristian Stătescu
Keyword(s):  
Cognitive Impairment ◽  
Cognitive Decline ◽  
Lifestyle Modification ◽  
Cognitive Disorders ◽  
Current Evidence ◽  
Barrier Dysfunction ◽  
Serum Triglycerides ◽  
Cerebral Amyloidosis ◽  
The Relationship

The burden of cognitive disorders is huge and still growing, however the etiology and the degree of cognitive impairment vary considerably. Neurodegenerative and vascular mechanisms were most frequently assessed in patients with dementia. Recent studies have shown the possible involvement of triglycerides levels in cognitive function through putative mechanisms such as brain blood barrier dysfunction or amyloid metabolism imbalance, but not all research in the field found this association. Several clinical studies evaluated the relationship between different forms of cognitive decline and levels of serum triglycerides, independent of other cardiovascular risk factors. This review focuses on the role of triglycerides in cognitive decline, cerebral amyloidosis and vascular impairment. Considering that the management of hypertriglyceridemia benefits from lifestyle modification, diet, and specific drug therapy, future studies are requested to appraise the triglycerides–cognitive impairment relationship.

scholarly journals Emerging strategies for the early detection and prevention of head and neck squamous cell cancer

2011 ◽  
Vol 227 (2) ◽  
pp. 467-473 ◽  
Author(s):  
Santanu Dasgupta ◽  
Rupesh Dash ◽  
Swadesh K. Das ◽  
Devanand Sarkar ◽  
Paul B. Fisher
Keyword(s):  
Early Detection ◽  
Head And Neck ◽  
Squamous Cell ◽  
Squamous Cell Cancer ◽  
Cell Cancer ◽  
Early Detection And Prevention ◽  
Neck Squamous Cell Cancer

Anxiety prevalence in coexisting alzheimer’s and thyroid pathology

2011 ◽  
Vol 26 (S2) ◽  
pp. 158-158
Author(s):  
I. Ioancio ◽  
R. Trascu ◽  
I. Turcu ◽  
L. Spiru
Keyword(s):  
Cognitive Impairment ◽  
Anxiety Disorder ◽  
Alzheimer Disease ◽  
Thyroid Function ◽  
Thyroid Disease ◽  
Clinical Manifestations ◽  
Cognitive Disorders ◽  
Thyroid Disorder ◽  
Thyroid Pathology ◽  
Normal Thyroid Function

BackgroundAlzheimer disease (AD) is one of the most common neurodegenerative disorders (prevalence boosts from 0.2% in patients aged 55-65 up to 27% in patients aged 85+ years. Clinical manifestations of psychiatric disorders accompanying hypo- and hyper-thyroid function can mimic cognitive impairment.ObjectivesOur study aimed at studying the relationship between thyroid pathology, anxiety disorder and Alzheimer disease (AD).MethodsOur longitudinal, prospective research followed 49 patients with thyroid disorders (aged 50-85 years, 93.5 females); 63.3% (n = 31) had coexisting dementia and thyroid disease while 36.7% (n = 18) were dementia-cleared (10 had mild cognitive impairment (MCI) and 8 - anxiety and/or depression); we cross/analyzed control (n = 18) and target (n = 31) groups.ResultsIn the target group, 64.5% (n = 20) had hypothyroidism, 22.6% (n = 7) had euthyroid function and 12.9% (n = 4) had hyperthyroidism. The prevalence of anxiety and depression was higher in the hypothyroidism + dementia group (55.5%, n = 11) than in the hypothyroidism-only group (44.4%, n = 8). Most controls (77.8%, n = 14) had hypothyroidism while 22% (n = 4) had normal thyroid function.ConclusionsAnxiety disorder had a greater prevalence both in the group with dementia + thyroid disease and in the MCI group. Hypothyroidism was the dominant thyroid disorder in both groups. The early diagnostic and treatment of thyroid disease is expected to improve prognosis and evolution of future cognitive disorders (MCI & AD).

Sign in / Sign up

Export Citation Format

Share Document